These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2782928)

  • 41. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
    Clark SJ; Saag MS; Decker WD; Campbell-Hill S; Roberson JL; Veldkamp PJ; Kappes JC; Hahn BH; Shaw GM
    N Engl J Med; 1991 Apr; 324(14):954-60. PubMed ID: 1900576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric HIV infection. An update.
    Sleasman JW; Scott GB
    J Fla Med Assoc; 1991 Oct; 78(10):673-7. PubMed ID: 1753232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
    Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J
    AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
    J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison of virus isolation and antigen enzyme immunoassay in the detection of HIV].
    Barrett PN; Dorner F; Stingl G; Heinz FX; Kunz C
    Wien Klin Wochenschr; 1989 Jun; 101(13):446-7. PubMed ID: 2503943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurologic manifestations of human immunodeficiency virus infection in children.
    Epstein LG; Sharer LR; Oleske JM; Connor EM; Goudsmit J; Bagdon L; Robert-Guroff M; Koenigsberger MR
    Pediatrics; 1986 Oct; 78(4):678-87. PubMed ID: 2429248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.
    Gibb DM; Duong T; Tookey PA; Sharland M; Tudor-Williams G; Novelli V; Butler K; Riordan A; Farrelly L; Masters J; Peckham CS; Dunn DT;
    BMJ; 2003 Nov; 327(7422):1019. PubMed ID: 14593035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Findings from a systematic ophthalmologic examination in carriers of the HIV antigen].
    Renaud J; Roué R; Bidaux F; Vignat JP
    Ophtalmologie; 1988; 2(2):167-9. PubMed ID: 3247156
    [No Abstract]   [Full Text] [Related]  

  • 49. Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy.
    Epstein LG; Goudsmit J; Paul DA; Morrison SH; Connor EM; Oleske JM; Holland B
    Ann Neurol; 1987 Apr; 21(4):397-401. PubMed ID: 3472486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnostico-prognostic significance of the analysis of anti-HIV antibodies and viral antigens in acquired immunodeficiency syndrome. Presentation of 2 paradigmatic cases].
    Venturini L; Serpelloni G; Parolin A; Mezzelani P
    G Clin Med; 1989 May; 70(5):353-6. PubMed ID: 2753265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastrostomy tube supplementation for HIV-infected children.
    Miller TL; Awnetwant EL; Evans S; Morris VM; Vazquez IM; McIntosh K
    Pediatrics; 1995 Oct; 96(4 Pt 1):696-702. PubMed ID: 7567333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine expression in the brain during the acquired immunodeficiency syndrome.
    Tyor WR; Glass JD; Griffin JW; Becker PS; McArthur JC; Bezman L; Griffin DE
    Ann Neurol; 1992 Apr; 31(4):349-60. PubMed ID: 1586135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Criteria for the appropriate drug utilisation of immunoglobulin.
    Thürmann P; Harder S
    Pharmacoeconomics; 1996 May; 9(5):417-29. PubMed ID: 10160254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection.
    Olopoenia L; Young M; White D; Barnes S; Rahbar F; Fomufod A
    J Natl Med Assoc; 1997 Aug; 89(8):543-7. PubMed ID: 9264222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does intravenous immune globulin have a role in HIV-infected patients?
    Yap PL
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):59-67. PubMed ID: 8033437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous immunoglobulin for secondary immunodeficiency.
    Yap PL
    Blut; 1990 Jan; 60(1):8-14. PubMed ID: 2404527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Newer uses of intravenous immunoglobulins as anti-infective agents.
    Pennington JE
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1463-6. PubMed ID: 2221853
    [No Abstract]   [Full Text] [Related]  

  • 58. Hyperviscosity in HIV infected children--a potential hazard during intravenous immunoglobulin therapy.
    Hague RA; Eden OB; Yap PL; Mok JY; Rae P
    Blut; 1990; 61(2-3):66-7. PubMed ID: 2207343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.
    Hammarström L; Smith CI
    Infection; 1990; 18(5):314-24. PubMed ID: 2125980
    [No Abstract]   [Full Text] [Related]  

  • 60. HIV infection and haemophilia.
    Jones P
    Arch Dis Child; 1991 Mar; 66(3):364-8. PubMed ID: 1902651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.